ARTICLE | Finance
Retail investors provide week’s only bright spots for biotech amid downturn
A handful of U.S. biotechs with products against COVID-19 rise sharply amid the turmoil
February 29, 2020 1:31 AM UTC
Updated on Mar 2, 2020 at 9:05 PM UTC
In a volatile week for markets spooked by fears of a spreading COVID-19 outbreak, retail investors have been driving volume in shares of a handful of U.S. biotechs pursuing products against the virus.
A late rally spared major indexes another day of steep declines Friday but they still ended the week in correction territory, with the Dow Jones Industrial Average falling 12%, the S&P500 losing 11% and the NASDAQ Composite dropping 11%...